Bid Price | 1.70p | High Price | 1.81p |
---|
Ask Price | 1.71p | Low Price | 1.70p |
---|
Open Price | 1.78p | Spread | 0.58% |
---|
Prev Close | 1.82p | Volume | 983,844 |
---|
Immupharma PLC Historic Prices
Date | Open | High | Low | Close | Volume |
---|
Oct 25, 2024 | 1.78 | 1.81 | 1.70 | 1.71 | 983,844 |
Oct 24, 2024 | 1.78 | 1.84 | 1.75 | 1.75 | 267,543 |
Oct 23, 2024 | 1.92 | 1.92 | 1.79 | 1.83 | 983,854 |
Oct 22, 2024 | 1.93 | 1.93 | 1.92 | 1.93 | 185,979 |
Oct 21, 2024 | 2.00 | 2.00 | 1.92 | 1.94 | 106,835 |
More Immupharma PLC Historic Prices >Immupharma PLC Information
Name | Immupharma PLC | Index | FTSE AIM All Share |
---|
ISIN | GB0033711010 | Epic | IMM |
---|
Type | Equity | Currency | GBX |
---|
Record Status | Active | Trading Segment | AMSM |
---|
Industry | Biotechnology | Sector | Healthcare |
---|
EMS | 250,000 | Trading Status | Closed |
---|
Shares in Issue | 416.44 m | Prev Close | 1.82p |
---|
PE Ratio | | Market Cap | £7.10 m |
---|
Div Yield | 0 | Div per Share | £NaN |
---|
EPS | £-0.00 | Div Cover | NaN |
---|
PEG | n/a | EPS Growth (%) | 0.00 |
---|
ROCE | -0.265967 | DPS Growth (%) | 0 |
---|
Current Ratio | 1.597239 | Quick Ratio | 1.045004 |
---|
Immupharma PLC Director Deals
Declared | Type | Director | Pos. | Volume / Price | Value |
---|
07/09/23 | BUY | Lisa Baderoon | NED | 1,000,000 @ £0.02 | £20,000.00 |
11/08/22 | BUY | Timothy McCarthy | CH | 1,200,000 @ £0.05 | £60,000.00 |
11/08/22 | BUY | Timothy Franklin | ED | 400,000 @ £0.05 | £20,000.00 |
11/08/22 | BUY | Lisa Baderoon | NED | 400,000 @ £0.05 | £20,000.00 |
24/08/21 | BUY | Timothy Franklin | ED | 125,000 @ £0.08 | £9,988.00 |
24/08/21 | BUY | Timothy McCarthy | CH | 250,000 @ £0.08 | £20,650.00 |
30/03/20 | PLAC | Robert Zimmer | RES | 2,000,000 @ £0.10 | £200,000.00 |
05/02/16 | PLAC | Franco Muzio | RES | 38,462 @ £0.26 | £10,000.00 |
05/02/16 | PLAC | Timothy McCarthy | CH | 38,462 @ £0.26 | £10,000.00 |
05/02/16 | PLAC | Dimitri Dimitriou | RES | 38,462 @ £0.26 | £10,000.00 |
More Immupharma PLC Director Deals >Immupharma PLC News